Pyeonghwa Jeong

Pyeonghwa Jeong

Auto-generated profile, based on publicly available information

Pyeonghwa Jeong

Department of Chemistry, Duke University, Durham, NC, 27708

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
KRKilian Roßmann
Kilian Roßmann
UPUlrich Pabst
Ulrich Pabst
BBBianca C. Baciu
Bianca C. Baciu
SSSiqi Sun
Siqi Sun
CHChristiane Huhn
Christiane Huhn
JBJohannes Broichhagen
Johannes Broichhagen
Visualization of proteins can be achieved by genetically grafting HaloTag Protein (HTP) into the protein of interest followed by incubation with a dye-linked HaloTag Ligand (HTL). This approach allows for use of fluorophores optimized for specific optical techniques or of cell-impermeable dyes to selectively label cell surface proteins. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Here we show that several dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed, using a one-step protocol. We validate such compounds, termed dye-SHTL (dye shuttle), in living cells, and demonstrate exclusive membrane staining. In transduced primary hippocampal neurons, we label a neuromodulatory receptor with dyes optimized for stimulated emission by depletion super-resolution microscopy, allowing accuracy in distinguishing surface versus internal receptors of the presynaptic terminal. This approach offers broad utility for surface-specific protein labelling.

27 October 2025 in ACS Infectious Diseases
Verified
Journal Article
Closed access
PDPatrick A. Dome
Patrick A. Dome
CCC. Skyler Cochrane
C. Skyler Cochrane
Hannah Joy SwitzerHannah Joy Switzer
Hannah Joy Switzer
HLHyejin Lee
Hyejin Lee
PJPyeonghwa Jeong
Pyeonghwa Jeong
PZPei Zhou
Pei Zhou

23 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KRKilian Roßmann
Kilian Roßmann
SSSiqi Sun
Siqi Sun
COChristina Holmboe Olesen
Christina Holmboe Olesen
MKMaria Kowald
Maria Kowald
ETEleni Tapp
Eleni Tapp
JBJohannes Broichhagen
Johannes Broichhagen
Communication between cells is largely orchestrated by proteins on the cell surface, which allow information transfer across the cell membrane. Super-resolution and single-molecule visualization of these proteins can be achieved by genetically grafting HTP (HaloTag Protein) into the protein of interest followed by brief incubation of cells with a dye-HTL (dye-linked HaloTag Ligand). This approach allows for use of cutting-edge fluorophores optimized for specific optical techniques or a cell-impermeable dye-HTL to selectively label surface proteins without labeling intracellular copies. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Traditional methods to eliminate cell permeability face synthetic bottlenecks and risk altering photophysical properties. Here we report that dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed. This simple, one-step method requires no purification and is compatible with both the original HTL and second-generation HTL.2, the latter offering accelerated labeling. We validate such compounds, termed dye-SHTL (‘dye shuttle’) conjugates, in live cells via widefield microscopy, demonstrating exclusive membrane staining of extracellular HTP fusion proteins. In transduced primary hippocampal neurons, we label mGluR2, a neuromodulatory G protein-coupled receptor (GPCR), with dyes optimized for stimulated emission by depletion (STED) super-resolution microscopy, allowing unprecedented accuracy in distinguishing surface and receptors from those in internal compartments of the presynaptic terminal, important in neural communication. This approach offers broad utility for surface-specific protein labelling.

20 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AMAlexander A. Mestre
Alexander A. Mestre
YOYunju Oh
Yunju Oh
JWJianli Wu
Jianli Wu
DDDenise Dunn
Denise Dunn
YSYasaman Setayeshpour
Yasaman Setayeshpour
JCJen-Tsan Ashley Chi
Jen-Tsan Ashley Chi
Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation and contributes to diverse pathologies including ischemia-reperfusion injury and neurodegenerative disorders. Current ferroptosis inhibitors largely function as nonspecific radical-trapping antioxidants, limiting their clinical utility. We previously identified MESH1 as a key regulator of ferroptosis through its NADPH phosphatase activity. Here, we identify 4,5,6,7-tetrabromo-1 H -benzotriazole (TBB) as a small molecule inhibitor of MESH1 with an IC 50 value of 4.7 ± 0.3 µM. X-ray crystallography revealed the molecular determinants of TBB recognition which are corroborated through structure-activity relationships of TBB analogs. TBB protected multiple cell lines against ferroptosis in vitro , and this effect was mitigated by MESH1 knockdown, consistent with on-target activity. Furthermore, TBB reduced neuronal death in an ex vivo brain slice model of Alzheimer’s disease. Collectively, these findings establish TBB as a bona fide small-molecule MESH1 inhibitor that suppresses ferroptosis and establishes MESH1 as a promising therapeutic target. Graphical Depicting mechanism of TBB suppressing ferroptosis through the inhibition of MESH1. Figure Created with Biorender.com

2 October 2025 in ACS Omega
Verified
Journal Article
Open access
EWEric C. Wang
Eric C. Wang
PJPyeonghwa Jeong
Pyeonghwa Jeong
CHChris Han
Chris Han
YOYunju Oh
Yunju Oh
YZYiquan Zhao
Yiquan Zhao
JHJiyong Hong
Jiyong Hong
The transient receptor potential vanilloid-1 (TRPV1) channel is a key mediator of pain perception and responds to various stimuli such as heat, low pH, and inflammation. Among TRPV1 antagonists, (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)-phenyl)-acrylamide (AMG8562) shows promise as a nonopioid analgesic, attenuating pain behaviors in rodent models without eliciting hyperthermic side effects commonly associated with other TRPV1 antagonists. Despite its potential, there has been limited research regarding the synthesis of AMG8562. Here, we present an asymmetric synthesis of AMG8562 featuring a lipase-catalyzed kinetic resolution of racemic 4-nitroindan-2-ol. This approach enables scalable access to enantiomerically pure material and provides a platform for the synthesis of structurally diverse AMG8562 analogues with potential for improved pharmacological properties.